Nektar Therapeutics
NKTR
#4624
Rank
NZ$4.15 B
Marketcap
NZ$122.99
Share price
6.76%
Change (1 day)
190.38%
Change (1 year)

Nektar Therapeutics (NKTR) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$1.34 Billion

According to Nektar Therapeutics 's latest financial reports the company's total assets are NZ$1.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$0.48 B-10.13%
2024-12-31NZ$0.53 B-14.4%
2023-12-31NZ$0.62 B-43.76%
2022-12-31NZ$1.11 B-31.57%
2021-12-31NZ$1.63 B-23.31%
2020-12-31NZ$2.13 B-27.36%
2019-12-31NZ$2.93 B-8.41%
2018-12-31NZ$3.20 B347.38%
2017-12-31NZ$0.71 B-12.75%
2016-12-31NZ$0.82 B12.72%
2015-12-31NZ$0.72 B29.26%
2014-12-31NZ$0.56 B6.59%
2013-12-31NZ$0.52 B-12.62%
2012-12-31NZ$0.60 B-22.14%
2011-12-31NZ$0.77 B15.03%
2010-12-31NZ$0.67 B-14.74%
2009-12-31NZ$0.79 B-17.97%
2008-12-31NZ$0.96 B2.04%
2007-12-31NZ$0.94 B-13.18%
2006-12-31NZ$1.09 B-13.19%
2005-12-31NZ$1.25 B20.32%
2004-12-31NZ$1.04 B10.03%
2003-12-31NZ$0.94 B-18.14%
2002-12-31NZ$1.15 B-27.86%
2001-12-31NZ$1.60 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$353.93 B 26,220.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$365.78 B 27,101.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$162.97 B 12,019.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$34.96 B 2,500.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$226.71 B 16,759.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$200.87 B 14,837.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.35 B-73.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$7.50 B 457.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland